DE60026011D1 - Orale verabreichung von taxoid derivaten - Google Patents

Orale verabreichung von taxoid derivaten

Info

Publication number
DE60026011D1
DE60026011D1 DE60026011T DE60026011T DE60026011D1 DE 60026011 D1 DE60026011 D1 DE 60026011D1 DE 60026011 T DE60026011 T DE 60026011T DE 60026011 T DE60026011 T DE 60026011T DE 60026011 D1 DE60026011 D1 DE 60026011D1
Authority
DE
Germany
Prior art keywords
oral administration
taxoid derivatives
taxoid
derivatives
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60026011T
Other languages
English (en)
Other versions
DE60026011T2 (de
Inventor
Marie-Christine Bissery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60026011D1 publication Critical patent/DE60026011D1/de
Application granted granted Critical
Publication of DE60026011T2 publication Critical patent/DE60026011T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60026011T 1999-01-13 2000-01-11 Orale verabreichung von taxoid derivaten Expired - Lifetime DE60026011T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99400072A EP1020188A1 (de) 1999-01-13 1999-01-13 Neue Verwendung von Taxoid-Derivaten
EP99400072 1999-01-13
PCT/EP2000/000943 WO2000041482A2 (en) 1999-01-13 2000-01-11 Oral administration of taxoid derivatives

Publications (2)

Publication Number Publication Date
DE60026011D1 true DE60026011D1 (de) 2006-04-20
DE60026011T2 DE60026011T2 (de) 2006-10-26

Family

ID=8241854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60026011T Expired - Lifetime DE60026011T2 (de) 1999-01-13 2000-01-11 Orale verabreichung von taxoid derivaten

Country Status (9)

Country Link
EP (2) EP1020188A1 (de)
AT (1) ATE317694T1 (de)
AU (1) AU3278400A (de)
CY (1) CY1106311T1 (de)
DE (1) DE60026011T2 (de)
DK (1) DK1140064T3 (de)
ES (1) ES2257286T3 (de)
PT (1) PT1140064E (de)
WO (1) WO2000041482A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417491B (zh) * 2011-10-31 2013-11-06 江苏红豆杉生物科技有限公司 以10-去乙酰基-巴卡丁iii为原料制备卡巴他赛的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain

Also Published As

Publication number Publication date
CY1106311T1 (el) 2011-10-12
PT1140064E (pt) 2006-06-30
WO2000041482A3 (en) 2000-11-02
ATE317694T1 (de) 2006-03-15
EP1020188A1 (de) 2000-07-19
DE60026011T2 (de) 2006-10-26
WO2000041482A2 (en) 2000-07-20
ES2257286T3 (es) 2006-08-01
EP1140064A2 (de) 2001-10-10
AU3278400A (en) 2000-08-01
DK1140064T3 (fr) 2006-06-12
EP1140064B1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
BR9609537A (pt) Composições farmacêuticas
ATE336029T1 (de) Lichtempfindliche zusammensetzung und 1,3-dihydro-1-oxo-2h-indenderivat
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DE69604653T2 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
DE69907137D1 (de) Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
DK0984773T3 (da) Farmaceutisk formulering med omeprazol
SE9904377D0 (sv) Pharmaceutical combinations
MA27086A1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
DZ1576A1 (fr) Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
FI971364A0 (fi) Kolkisiinijohdannaiset ja niiden terapeuttinen käyttö
DE60026011D1 (de) Orale verabreichung von taxoid derivaten
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
DE3879985D1 (de) Anticonvulsive agenzien.
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
BR1100929A (pt) Derivados 1,2-difenilpirrol e uma composição farmacêutica

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC